Company
CureVac N.V. (0001809122)
Standardized SEC financial data for CureVac N.V. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001809122 · Pharmaceutical Preparations.
Return on equity
23.3%
Income statement
| € | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|---|
| Cost of revenue | €28.0M | €14.2M | €238.2M | €184.0M | €124.4M | €105.8M |
| R&D expense | €43.2M | €113.8M | €815.9M | €62.5M | €115.7M | €153.0M |
| SG&A expense | €49.0M | €53.6M |
Standardized from CureVac N.V.'s SEC filings — per-share figures split-adjusted. Full history via the API.
Balance sheet
| € | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|---|
| Total assets | €130.6M | €1.51B | €1.16B | €860.5M | €788.2M | €802.8M |
| Total liabilities |
Get 0001809122 data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/0001809122/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/0001809122/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"